Swetha Sampathgiri
About Swetha Sampathgiri
Swetha Sampathgiri is the Associate Director of Drug Substance Operations at Bristol Myers Squibb, with extensive experience in validation engineering and CMO relationship management.
Title and Current Position
Swetha Sampathgiri is currently the Associate Director of Drug Substance Operations at Bristol Myers Squibb. She has been in this position since November 2022 and operates from the Greater Bengaluru Area.
Professional Experience at Biogen
Before her current role, Swetha Sampathgiri worked at Biogen for an extensive period. Her roles included CMO Relationship Manager (Drug Product/ Fill Finish) from 2019 to 2022 in Zug, Switzerland, Senior Validation Engineer (Biologics Drug Substance) from 2017 to 2019 in Zug, Switzerland, Senior Project Engineer, Global Capital Projects from 2016 to 2017 in Cambridge, Massachusetts, United States, and Senior Validation Engineer from 2009 to 2016 in Cambridge, Massachusetts, United States.
Previous Roles and Early Career
Swetha began her career with internships at Biocon in 2004 and bigtec Private Limited in 2005. She also worked at Reliance Industries Limited as a Technical Management Trainee in Central Technical Services from 2006 to 2007 in Surat, Gujarat, India, and as a Project Associate at Adelphi Focus in 2008 for a brief period in Allentown, Pennsylvania, United States. Her early career laid a strong foundation in the technical and project management domains.
Expertise in Drug Substance Operations
Swetha Sampathgiri has extensive experience in drug substance operations, enhanced by her various roles at Biogen and now at Bristol Myers Squibb. This includes a robust background in validation engineering and managing CMO relationships as well as her involvement in global capital projects. Her diverse international experience across Switzerland, the United States, and India further enriches her professional portfolio.